The Axial Spondyloarthritis International Foundation (ASIF) is encouraging members of the ankylosing spondylitis community to wear orange shoelaces…
Articles by Marisa Wexler MS
The U.S. Food and Drug Administration (FDA) has agreed to review an application seeking approval of AVT05, a proposed biosimilar…
One year of treatment with Rinvoq (upadacitinib) reduced disease activity for most adults with non-radiographic axial spondyloarthritis (nr-axSpA) —…
Machine learning and deep learning are already showing promise as tools to help diagnose and manage ankylosing spondylitis (AS),…
Up to five years of treatment with bimekizumab safely leads to sustained reductions in symptoms and disease activity,…
People with ankylosing spondylitis (AS) who carry a mutation in the gene that encodes the CARD9 protein may be…
A form of exercise using a device that mimics horseback riding may be an effective intervention to boost muscle strength,…
Treatment with Rinvoq (upadacitinib) substantially reduced disease activity for most adults with ankylosing spondylitis (AS) who had…
More than a dozen genes related to inflammatory cell death were found to be expressed at atypical levels in…
Seven genes — from a pool of four dozen identified as being different in people with ankylosing spondylitis (AS)…